Furthermore, it has been found that in HER2-positive breast cancers, also expressing steroid hormone receptors for estrogen, progesterone, or both, the content of steroid hormone receptors is lower than in HER2-negative, hormone-receptor-positive tumors. Here, ERBB2 is linked to breast carcinoma.